Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 20 mg + 500 mg
Send MessageTeneligliptin & Metformin ER Tablets are a fixed-dose combination therapy formulated to deliver comprehensive glycemic control in patients with type 2 diabetes mellitus. This combination brings together Teneligliptin, a potent DPP-4 inhibitor that prolongs incretin hormone activity, with Metformin in an extended-release (ER) form, which decreases hepatic glucose production and enhances peripheral insulin sensitivity.
By targeting both insulin secretion and insulin resistance, this dual-action formulation ensures effective regulation of blood glucose levels throughout the day. The ER technology of Metformin allows gradual drug release, improving gastrointestinal tolerability and ensuring sustained therapeutic effect, making it suitable for long-term diabetes care.
Genliva Wellness LLP, Himatnagar, India, is a reliable teneligliptin metformin ER tablet manufacturer India, offering high-quality combination antidiabetic formulations for domestic markets, global exports, and contract manufacturing services.
Teneligliptin & Metformin ER Tablets combine a DPP-4 inhibitor with extended-release Metformin to provide effective and sustained blood glucose control in type 2 diabetes mellitus. The formulation helps improve incretin activity, insulin response, and glucose metabolism with prolonged therapeutic support.
These tablets are prescribed for patients with type 2 diabetes mellitus who require combination therapy for improved blood sugar management. They help maintain stable glucose levels along with diet and lifestyle modifications.
Teneligliptin & Metformin ER Tablets provide dual-pathway glucose control with extended-release therapeutic action and improved metabolic stability for effective diabetes management.
